|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 59.85 USD | +3.74% |
|
+2.94% | -26.91% |
| 07-16 | RxSight Names Aziz Mottiwala as CEO | MT |
| 07-14 | Tarsus Pharmaceuticals, Inc. Announces Management Changes, Effective July 13, 2026 | CI |
Main competitors
| Change | 5-day change | 1-month change | 3-month change | YTD change | 1-year change | 3-year change | 5-year change | 10-year change | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
 | +3.74% | +2.94% | -5.24% | -10.99% | -26.91% | +38.38% | +197.61% | +133.70% | - | 2.57B | |
| -0.33% | +1.83% | +10.94% | -9.84% | -12.33% | +24.73% | -5.89% | +15.63% | +79.42% | 68.85B | |
| +0.50% | +1.91% | -3.03% | -7.30% | +0.63% | +38.55% | +192.52% | +170.87% | +246.26% | 52.13B | |
| +0.94% | +39.60% | +39.60% | +39.60% | +39.60% | +39.60% | +39.60% | +39.60% | - | 43.46B | |
| -0.58% | +1.05% | +8.62% | -10.78% | -28.98% | -51.98% | -53.78% | -57.20% | +4.79% | 41.24B | |
| -1.40% | +3.43% | +4.79% | +16.15% | +17.05% | +64.81% | -25.61% | -36.45% | -20.72% | 30.41B | |
| -2.11% | -9.45% | -3.35% | +15.08% | +109.63% | +97.76% | -50.61% | -80.29% | - | 24.53B | |
| +0.51% | +0.46% | +19.37% | +19.86% | +18.71% | +72.78% | +86.41% | +51.17% | +41.57% | 23.42B | |
| +3.99% | +3.82% | +22.76% | +1.54% | +21.31% | +4.34% | +196.00% | +6.20% | - | 19.75B | |
| -0.28% | -0.17% | +3.51% | +10.14% | +38.34% | +71.15% | +125.24% | +186.67% | +326.69% | 16.57B | |
| +1.34% | -5.25% | +22.80% | +6.03% | +6.39% | +74.97% | +136.16% | +41.75% | - | 15.95B | |
| -2.97% | -1.63% | -8.18% | +21.70% | +25.93% | +105.91% | +209.81% | +310.06% | +2,822.49% | 11.84B | |
| -0.68% | +0.79% | +8.96% | +9.06% | +0.27% | +4.01% | -31.57% | -24.35% | -34.10% | 11.52B | |
| +3.82% | -2.99% | +1.95% | +29.41% | +43.94% | +140.60% | +181.39% | +480.88% | - | 10.46B | |
| -4.16% | -14.66% | -21.78% | -24.45% | -38.49% | -43.57% | +557.55% | +276.62% | +4,270.58% | 9.96B | |
| +3.11% | +4.87% | +3.52% | -0.32% | -12.67% | -21.08% | -31.80% | -54.57% | -53.32% | 6.28B | |
| +2.87% | +3.55% | +7.18% | +56.91% | +195.87% | +166.85% | +260.82% | -18.54% | - | 5.84B | |
| -13.72% | -16.53% | +9.76% | -25.49% | +7.27% | +9.23% | +249.19% | +244.85% | - | 5.83B | |
| -7.39% | -3.31% | +13.35% | -1.35% | -5.58% | +9.36% | +52.30% | -23.70% | - | 5.64B | |
| -4.52% | -0.66% | +0.04% | -28.01% | -36.47% | -52.43% | -55.40% | -78.82% | - | 5.33B | |
| Average | -0.74% | -1.72% | +6.78% | +5.35% | +18.18% | +39.70% | +111.50% | +79.20% | +768.37% | 20.58B | |
| Weighted average by Cap. | -0.13% | -0.70% | +9.85% | +5.50% | +13.88% | +36.27% | +73.16% | +56.58% | +365.42% |
- Stock Market
- Stocks
- TARS Stock
- Sector Tarsus Pharmaceuticals, Inc.
Select your edition
All financial news and data tailored to specific country editions
